We identified 16 randomized controlled trials (RCTs) of methods for weaning patients from mechanical ventilation, 8 of which were trials of discontinuation assessment strategies, 5 of which were trials of stepwise reduction in mechanical ventilatory support, and 3 of which were trials comparing alternative ventilation modes for weaning periods lasting < 48 h. We found that different thresholds for deciding when a patient is ready for a trial of spontaneous breathing, different criteria for a successful trial, and different thresholds for extubation may overwhelm the impact of alternative ventilation strategies. Nevertheless, the results of these studies suggest the possibility that multiple daily T-piece weaning or pressure support may be superior to synchronized intermittent mandatory ventilation. Other RCTs suggest that early extubation with the back-up institution of noninvasive positive-pressure ventilation as needed may be a useful strategy in selected patients.
T he weaning process begins in practice, and in many clinical studies, when clinicians decide that a patient may be able to tolerate a reduction of mechanical ventilatory support. 1 At that point, there are several options for decreasing support, some of which may be more successful than others. 2 The options include, but are not restricted to, intermittent T-piece trials, synchronized intermittent mandatory ventilation (SIMV), pressure support (PS) weaning, continuous positive airway pressure (CPAP), combinations of the foregoing, and newer approaches to weaning such as volume support, proportional assist ventilation, and noninvasive positive pressure ventilation (NPPV).
Clinicians reach another stage in the weaning process at the point at which they suspect a patient may tolerate the discontinuation of mechanical ventilatory support and extubation. The most popular method of proceeding at this point is a T-piece trial. However, there are several alternatives, including supporting the patients through the trial of spontaneous breathing with low-level CPAP, PS, or positive end-expiratory pressure (PEEP). Within each of these approaches, numerous alternatives exist such as T-piece trials of various durations, and different levels of CPAP and PS.
In this systematic review, we begin with trials of the discontinuation of mechanical ventilation, continue with trials of stepwise reductions in mechanical ventilatory support, and, finally, present results of the third set of trials that focused on the last 48 h of the weaning process.
Materials and Methods

Eligibility Criteria
Our methodology is reported in detail elsewhere in this supplement. For the reviews in this section, we focused on strategies that were designed to facilitate weaning and extubation that involved alternative regimens of assessing suitability for weaning or extubation or alternative strategies for ventilating patients during the weaning process. We excluded studies that reported exclusively physiologic outcomes. We included randomized trials and observational studies that included a control group.
Search for Relevant Studies
To identify relevant studies, we searched MEDLINE, Excerpta Medica Database, Health Services Technology Administration and Research, Cumulative Index to Nursing and Allied Health Literature, the Cochrane Controlled Trials Registry, and the Cochrane Data Base of Systematic Reviews from 1971 to 1999. Search strategies are available on request. We examined the reference lists of all included articles for other potentially relevant citations. In addition, we hand searched the journal Respiratory Care from 1997 to 1999. We did not explicitly search for unpublished literature.
Two reviewers examined each title and abstract. We retrieved all articles that either reviewer considered to be possibly eligible. Two reviewers also examined the full text and made final decisions regarding eligibility based on the inclusion and exclusion criteria described earlier. These decisions were made unblinded to the source, authors, and conclusions of each study. The reviewers resolved disagreements by consensus.
Data Abstraction and Assessment of Methodological Quality
Two reviewers abstracted the data and assessed the methodological quality of each study. Reviewers resolved disagreements through discussion or consultation with one of the investigators. Final data abstraction was rechecked by one of the investigators.
The methodological features of randomized trials that we abstracted included the following: the method of randomization and whether randomization was concealed; the criteria used to describe weaning, extubation, and reintubation; the extent to which groups were similar with respect to important prognostic factors; whether investigators conducted an intention-to-treat analysis; whether patients, clinicians, and those assessing outcome were blind to allocation; the extent to which the groups received similar cointerventions; and reporting of the reasons for study withdrawal.
Because it is a relatively new methodological term, the issue of concealment deserves further comment. A study is concealed if those making the judgment about whether a patient is eligible to be enrolled is unaware, at the time they are making this decision, whether a patient will be allocated to the experimental or control group. Lack of concealment theoretically may destroy the balance in prognostic factors that investigators strive to achieve through randomization. For instance, those making decisions about eligibility and enrollment may systematically exclude sicker patients if they know these patients are going to be allocated to the treatment group. Some empirical data suggest that unconcealed studies yield systematically larger treatment effects than do concealed studies. 3, 4 For nonrandomized controlled clinical trials, we considered the extent to which groups were similar with respect to important prognostic factors, whether the investigators adjusted for differences in prognostic factors, and the extent to which the groups received similar cointerventions.
Statistical Analysis
When we found duplicate reports of the same study in preliminary abstracts and articles, [5] [6] [7] [8] [9] [10] we used the most complete information. 8, 9, [11] [12] [13] We divided our approaches to synthesis (and subsequently our results) into studies dealing with randomized and nonrandomized controlled comparisons of alternative weaning interventions, and observational studies addressing the prediction of successful weaning and the duration of mechanical ventilation.
We began by identifying all the interventions and outcomes addressed by randomized trials. We abstracted or, when necessary, calculated effect sizes in terms of relative risks and associated 95% confidence intervals (CIs) for binary outcomes, and mean differences and 95% CIs for continuous variables. We transformed interquartile ranges into SDs when necessary to obtain variance estimates for testing differences between groups. The 95% CIs are not reported when variance data either were not provided by authors or were not estimable using either a precise p value or an interquartile range.
We reviewed the interventions and outcomes, and we decided when it was legitimate to pool across studies and when it was not. When pooling was not appropriate, we divided studies into categories according to the similarity of interventions.
We pooled data when, in our judgment, the underlying pathophysiology was such that across the range of populations, the management strategies in treatment and control groups, and the key outcomes studied we would expect more or less the same treatment effect. In general, we did not see differences in the distributions of characteristics of populations between studies as an impediment to pooling. For instance, consider two studies of the same weaning strategy. One enrolled patients a mean of 8 days after the onset of mechanical ventilation, another a mean of 14 days after onset. However, both studies enrolled some patients after 3 days of receiving mechanical ventilation, and others after 3 months. Thus, the individual studies are themselves pooling data from patients with the full spectrum of duration of mechanical ventilation. When interventions, outcomes, and trial methodology are similar, we do not see serious impediments to pooling in this sort of situation.
For instances in which we could pool data, for continuous variables we considered the mean in each group and an estimate of variability from each group which determined the weight given to the study in the pooled analysis. For pooling binary data, we calculated risk ratios using the methods described by Fleiss. 14 We constructed 2 ϫ 2 tables in each study for which the data were available and calculated the associated risk ratios. For both continuous and binary variables, we tested for heterogeneity using a test based on the 2 distribution with N Ϫ1 degrees of freedom, in which N signifies the number of studies. When we found clinically important heterogeneity that could not be explained by the play of chance, we reviewed the methodology of the original studies in search of explanations of the differences in outcome. All our analyses are based on a random-effects model.
For nonrandomized studies that compared alternative weaning interventions, we used similar methodologies for calculating point estimates and 95% CIs for individual studies but made no attempt to pool data across studies.
Results
We identified 16 randomized trials, 15 through MED-LINE and 1 through Excerpta Medica Database. [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] One set of trials deals with the decision about what mode of ventilation to use to test the patient's ability to tolerate unassisted breathing. Of the 16 randomized trials, 8 trials [15] [16] [17] [18] [19] [20] [21] [22] dealt with this choice. We refer to this group of studies as "studies comparing alternative discontinuation assessment strategies."
In the second clinical context that we identified, the clinician faces a patient whose condition is improving, but who is unlikely to tolerate unassisted ventilation for at least 24 h, and perhaps up to several days. The clinician wishes to progressively decrease the level of mechanical support and has a number of modes available to achieve this goal. Five [23] [24] [25] [26] [27] of the 16 randomized trials dealt with this context. We refer to this group of trials as "studies comparing alternative ventilation modes for stepwise reductions in mechanical support."
A third set of three trials focused on the last 48 h of the weaning process. 28 -30 
Trials of Discontinuation Assessment Strategies
The sample size of the eight randomized studies of discontinuation assessment strategy modes varied from 18 to 526. Three of the studies enrolled Ͼ 100 patients (Table 1) . [15] [16] [17] [18] [19] [20] [21] [22] The largest studies 21, 22 were methodologically strong, reporting the method of randomization and weaning, extubation, and reintubation criteria. A lack of concealment of randomization could easily bias the results of these studies, and, while none of the studies used the optimal method of ensuring concealment (ie, randomization by an independent methods center), the studies by Esteban and coworkers 21, 22 used the next best approach for a study such as this, opaque sealed envelopes. Other randomized trials were not as strong methodologically (Table 1) .
The first study by Esteban et al 21 compared 2-h trials of unassisted breathing using PS of 7 cm H 2 O vs a T-piece. A smaller proportion of patients in the PS group (14%) failed to tolerate the weaning and to achieve extubation at the end of the 2-h trial than in the T-piece group (22%; relative risk, 0.64; 95% CI, 0.43 to 0.94) ( Table 2 ). Of those patients who were extubated, 38 in the PS group and 36 in the T-piece group required reintubation ( Table 2 ).
The second study by Esteban et al 22 compared a 30-min to a 120-min T-piece trial of spontaneous breathing prior to extubation. There was no reported difference in the rate of reintubation between groups, and patients who were randomized to the shorter T-piece trial benefited from statistically significant reductions in ICU and hospital lengths of stay (2 days and 5 days shorter, respectively).
The other randomized studies, all of which compared T-piece strategies to alternative strategies usually including some form of PS, had much smaller sample sizes, and generally had lower event rates. The result is very wide 95% CIs around any effect estimates (Table 2 ). Our judgment was that we could pool only across two trials that compared T-piece breathing to CPAP, and, even after pooling, the number of events was so low that the 95% CIs were extremely wide (relative risk for nonextubation in CPAP vs T-piece breathing, 1.66 [95% CI, 0.60 to 4.64]; relative risk for reintubation, 1.61 [95% CI, 0.39 to 6.59]) (Table 3) .
Controlled Trials of Stepwise Reduction in Mechanical Support
Five randomized controlled trials (RCTs) compared alternative methods of reducing ventilatory support in patients in whom clinicians thought that extubation was still several days away. [23] [24] [25] [26] [27] The sample sizes of the RCTs varied from 19 to 130 patients, with two trials having enrolled Ͼ 100 patients ( Table 4) . Three of the trials, including the two largest ones, used sealed opaque envelopes to protect concealment and described the criteria for weaning and extubation. The most informative results come from the two largest studies by Esteban et al 25 and Brochard et al. 23 These two studies compared the following three modes of reducing ventilatory support that were delivered in similar ways in the two studies: multiple daily T-piece breathing; PS; and SIMV. The trial by Esteban et al 25 also included a fourth arm, once-daily T-piece breathing, which demonstrated results very similar to the multiple daily T-piece breathing (Table 5) .
In both studies, the investigators recruited patients who had already failed a T-piece trial of unassisted breathing. Esteban and colleagues 25 conducted their T-piece trial of unassisted breathing in 546 patients, only 130 of whom had respiratory distress during a 2-h T-piece trial. Brochard et al 23 found a similar strikingly high proportion of patients who tolerated their 2-h T-piece trial of unassisted breathing. Of 456 patients who underwent the T-piece trial, only 109 had been unable to tolerate spontaneous breathing and, therefore, were randomized.
Of those randomized, patients in the trial by Esteban et al 25 had a prior mean duration of mechanical ventilation of approximately 9.3 days, with a minimum of 24 h of ventilatory support. The patients in the study by Brochard et al 23 also had a minimum duration of ventilation of 24 h, with an approximate mean duration of ventilation of 14 days.
Because the populations and interventions of the two studies are reasonably similar, we pooled the results for the outcomes that were measured in similar ways (Table *Values given as mean Ϯ SD, unless otherwise indicated. I ϭ inspiration; E ϭ expiration; RV ϭ right ventricular; Vt ϭ tidal volume; MPAP ϭ mean pulmonary artery pressure; PCWP ϭ pulmonary capillary wedge pressure; PVRI ϭ pulmonary vascular resistance index; RVEF ϭ right ventricular ejection fraction; MAP ϭ mean arterial pressure; Vt ϭ tidal volume; P(A Ϫ a)O 2 ϭ alveolar-arterial oxygen pressure difference; LOS ϭ length of stay; NE ϭ no estimate of variance available or calculable; combined end point ϭ nonextubation ϩ reintubation; VC ϭ vital capacity; MIP ϭ mean inspiratory pressure. †Int 1 ϭ intervention 1 (CPAP, 5 cm H 2 O); Int 2 ϭ intervention 2 (T-piece breathing). ‡Values given as differences in the mean (95% CI). §Values given as relative risk (95% CI). 6). Table 6 presents with the duration of ventilation and the relative risk of the combined end point of nonextubation in 2 to 3 weeks and the need for reintubation. In the comparison of T-piece breathing to PS, the pooled results showed no difference in the duration of ventilation, the trends going in opposite directions in the two studies ( Table 6 ). The results of the trial by Esteban et al 25 favored weaning with T-piece breathing, and those of the trial by Brochard et al 23 favored PS. As a result, the 95% CI around the pooled estimates for both the duration of ventilation and the relative risk of nonextubation or reintubation is extremely wide.
In the comparison of T-piece breathing to SIMV, the two trials showed similar trends in favor of T-piece in the duration of ventilation. The 95% CI around the pooled results comes close to excluding no difference, with the magnitude of the pooled estimate being a difference of Ͼ 40 h additional duration of ventilation in favor of the T-piece breathing strategy for weaning, or a relative risk of the combined end point of 1.48 in the SIMV group (Table 6 ).
In the comparison of PS to SIMV on the duration of weaning, both studies found trends in favor of PS, although the effect in the study by Brochard et al 23 was much larger. The magnitude of the trend in the pooled result for the duration of ventilation was Ͼ 60 h, and the 95% CI came close to excluding no effect. The pooled results of PS vs SIMV on the combined end point showed an extremely wide 95% CI.
Jounieaux et al 24 randomized 19 patients to SIMV with PS vs SIMV without PS. Neither group received CPAP. The duration of the weaning process was approximately 1 day shorter in the group that received PS, with the lower boundary of the 95% CI being approximately 7 h (Table  5 ). Two patients in the SIMV group, and none in the group that also received PS, required reintubation.
Two groups of investigators 26, 27 evaluated NPPV as a mode for stepwise reductions in mechanical ventilatory support for patients admitted to the hospital with COPD exacerbations who had failed a 2-h T-piece breathing trial. The control strategies in the two studies included PS ventilation, with or without CPAP. In the larger study, Nava et al 26 found that a reduction in the duration of mechanical ventilation, which was associated with a reduction in ICU stay of almost 9 days, was associated with NPPV (Table 5 ). Pooling the results of these studies, the reduction in ICU length of stay was 5 days (95% CI, Ϫ12.2 to ϩ1.9 days) ( Table 7) . Pooling also indicated favorable trends in mortality (relative risk, 0.30; 95% CI 0.09 to 1.02) and in the incidence of nosocomial pneumonia (relative risk, 0.29; 95% CI, 0.02 to 3.88).
Two additional nonrandomized trials evaluated the use of NPPV in the process of weaning. Patel et al 31 bation rate in the patients receiving invasive CPAP vs noninvasive CPAP. Hilbert and colleagues 32 evaluated NPPV in COPD patients who developed hypercapnic respiratory insufficiency after extubation. Comparing patients who had been managed with NPPV to historical control subjects, there was a statistically significant reduction in the rate of reintubation with NPPV and a nonsignificant survival benefit.
Trials Comparing Alternative Ventilation Modes for Weaning Lasting Ͻ 48 h
Three randomized trials addressed an intermediate group of patients who were not yet ready for discontinuation assessment, but who were likely to be ready within 48 h. 28 -30 These trials were methodologically relatively weak and included sample sizes of Ͻ 42 patients (Table 8) . Chopin et al 28 showed a trend in favor of CO 2 mandatory ventilation over intermittent mandatory ventilation (IMV) and multiple daily T-piece breathing in the proportion of patients extubated at 24 h. However, there were only 14 patients in each of the three study groups (Table 9) .
Davis et al 29 compared IMV weaning from ventilatory support (18 patients) to weaning based on setting the mandatory minute volume (MMV) to 75% of the minute volume prior to commencing weaning. The MMV was achieved by decreasing the frequency and maintaining the tidal volume. Patients who were weaned quickly from ventilatory support did so in Ͻ 5 h in the MMV group and in Ͼ 30 h in the IMV group (Table 9 ). Five patients in each group failed to wean quickly, and the authors do not tell us more about these patients.
The study by Esen et al 30 showed trends in favor of PS over IMV in both the duration of ventilation and the success of extubation in 48 h (Table 9) .
Two non-RCTs 33,34 also examined alternative weaning modes for patients who were expected to be weaned very Table 2 for abbreviations not used in the text. †Int 1 ϭ intervention 1 (PS with or without CPAP); Int 2 ϭ intervention 2 (SIMV with or without CPAP); Int 3 ϭ intervention 3 (multiple daily T-piece breathing). ‡Values given as differences in the mean (95% CI). §Values given as relative risk (95% CI). Int 1 ϭ intervention 1 (SIMV plus PS without CPAP); Int 2 ϭ intervention 2 (SIMV without CPAP). ¶Int 1 ϭ intervention 1 (PS with or without CPAP); Int 2 ϭ intervention 2 (SIMV with or without CPAP); Int 3 ϭ intervention 3 (multiple daily T-piece breathing); Int 4 ϭ intervention 4 (once-daily T-piece breathing). #Int 1 ϭ intervention 1 (extubation and noninvasive positive-pressure ventilation); Int 2 ϭ intervention 2 (PS with or without CPAP). **Int 1 ϭ intervention 1 (noninvasive ventilation); Int 2 ϭ intervention 2 (PS).
quickly from mechanical ventilation, with similar findings to those of the RCTs. Tomlinson et al 33 found no difference in the duration of mechanical ventilation or the duration of weaning in medical-surgical ICU patients who were weaned from ventilatory support over a period of 2 h to (rarely) 3 days using IMV (without CPAP) vs multiple daily T-piece breathing trials. In contrast, Rathgeber et al 34 compared the following in the weaning of 586 patients who had undergone cardiac surgery: (1) the use of T-piece breathing trials; (2) the use of SIMV; or (3) the use of invasive bilevel pressure ventilation. The results of this study suggested a superiority of bilevel pressure ventilation (ie, CPAP plus PS) over weaning with T-piece breathing, and a superiority for both of these modes over weaning with SIMV, with respect to the duration of mechanical ventilation.
Discussion
These trials have made important observations that are relevant to the care of patients receiving mechanical ventilation, and they represent one of the most wellstudied fields in critical-care medicine. We begin with an observation that is applicable to all trials of alternative ventilation modes. A major outcome of these studies of modes of weaning is weaning failure and, in particular, the need for reintubation. While the need for reintubation is important, it is prior to reintubation that patients often experience distress, the most important consequences of which is major morbidity such as pneumonia, further lung injury or cardiac complications, and possibly death. To this extent, reintubation is a surrogate outcome. These same Tables 2 and 3 for abbreviations not used in the text.
CHEST / 120 / 6 / DECEMBER, 2001 SUPPLEMENT complications may result from prolonged ventilation prior to any attempt to extubate. Most studies to date lack the sample size to definitively address the important putative consequences of prolonged mechanical ventilation and reintubation.
Controlled Trials of Alternative Discontinuation Strategies
Because of small sample sizes and low event rates, most of the randomized trials have provided little information about the relative impact of different modes of weaning. The results of the second largest trial, by Esteban et al, 21 have suggested a possible advantage of PS over a T-piece trial of spontaneous breathing. The results of the largest trial, also by Esteban et al, 22 have suggested a possible advantage to 30-min T-piece breathing trials over 2-h T-piece breathing trials with respect to ICU and hospital lengths of stay.
A major theme that was found in other areas of weaning research emerges from review of the RCTs of unassisted ventilation in patients who the clinician anticipates are ready for extubation. Irrespective of the interventions being compared, studies examining the impact of short periods of spontaneous breathing with or without some form of support show very different rates of failure of extubation, or of reintubation. For instance, looking at the two largest trials, Esteban and colleagues 21 found that 22% of 246 patients failed a T-piece weaning trial, and of the 192 who were extubated, 19% required reintubation. In contrast, Jones and coworkers 17 reported that only 4% of 52 patients undergoing weaning with T-piece breathing were not extubated, and of those extubated, only 4% of 50 patients required reintubation.
These discrepancies suggest that investigators are using quite different criteria when judging whether a patient is ready for a trial of spontaneous breathing and for judging when the trial is a success and extubation is appropriate. When investigators explicitly described their criteria, the differences were not obvious. Nevertheless, differences in criteria must partially explain these differences in failure rates. Even if patients began with quite different unmeasured and undescribed differences in characteristics, clinicians must have been using different criteria for judging patient suitability for trials of unassisted breathing or extubation. Were this not the case, patients with a similar likelihood of succeeding would have been chosen for trials of unassisted breathing, or of extubation, from the initially dissimilar populations.
These varying criteria have a number of implications. First, because a particular weaning strategy is superior in a setting in which the threshold for a weaning trial, or for extubation, is low, does not mean that it will be superior in a setting in which the threshold is much higher. In fact, in those settings in which the threshold is high, and failure rates are Ͻ 5%, the absolute superiority of one approach over another will be small or perhaps negligible. The other implications of these varying criteria have to do with future research.
In the setting of a high threshold and low failure rates, investigators would need to recruit patient sample sizes in the thousands, or even the tens of thousands, to convincingly demonstrate differences between techniques. Such studies are unlikely to be feasible, and, even if they were feasible, they would consume substantial resources. Thus, investigators interested in studying the optimal use of ventilation strategies for weaning in the future should first establish plausible event rates, and if they are very low, should reconsider embarking on trials comparing alternative approaches. In situations in which event rates are high, it would be reasonable to reexamine whether a difference between PS and T-piece breathing could be confirmed.
Since the effect of different thresholds appears to overwhelm the impact of alternative ventilation approaches, perhaps investigators should study the use of these alternative thresholds. The randomized trials often specify that patients become eligible for studies when clinicians judge they are ready for decreasing ventilatory support or for a trial of unassisted ventilation. Since it is this decision that largely determines the outcome, the decision process or criteria warrant intense scrutiny. Some investigators have made their criteria explicit, but apparently similar explicit criteria yield very different results. Thus, there are subtleties in the decision-making process that have not yet been elucidated.
On the surface, it seems that clinicians who choose a high threshold and reduce failed trials of spontaneous breathing or reintubations to a minimum may be doing the best job. This is not necessarily so. Low rates of failure for breathing trials or reintubations are likely to come at the 
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Evidence-Based Guidelines for Weaning and Discontinuing Ventilatory Support price of a prolonged duration of ventilation. Thus, a worthy goal for future research would be to delineate the tradeoff between prolongation of ventilation and failed trials of spontaneous breathing, and, more importantly, between prolongation of ventilation and reintubation. In other words, what is the cost, in terms of failed extubations, of decreasing weaning time by a particular amount? Even if we knew the relationship between decreased weaning time and extubation failure, this would not in itself tell us the optimal tradeoff. For instance, were a study to find that a higher threshold decreased reintubation rates from 10 to 5% (we note that 570 patients per group would be required for an adequately powered study with these event rates) with patients spending a mean of an additional 24 h on the ventilator, which threshold would be judged to be optimal? Investigators interested in pursuing the issue of optimal ventilation strategies, and particularly an optimal threshold, should give careful thought to this issue.
Controlled Trials of Stepwise Reduction in Mechanical Ventilatory Support
The issue of different thresholds that was so evident in the randomized trials of unassisted ventilation is also relevant in randomized trials of various modes for progressive reduction in mechanical support. For instance, the mean duration of weaning in the T-piece breathing group in the trial by Brochard et al 23 was 8.5 days, and in the study by Esteban et al, 25 3 days. Herein, the major focus of judgment may be issues of patient selection (although the reasons for differences are not apparent from the descriptions of the recruiting process) and the judgment as to when the weaning process begins.
The results of these studies suggest the possibility that weaning with multiple daily T-piece breathing, or PS, may be superior to SIMV. Even for this comparison, however, the 95% CIs on pooled estimates approach no effect. The results of two studies 23, 25 of weaning in Ͻ 48 h provide further evidence that SIMV may be less advantageous than other methods of decreasing mechanical ventilatory support. However, these trials compared particular SIMV weaning regimens. Other weaning regimens using SIMV may produce different results. This is also true of the other weaning modes studied. For instance, the criteria for weaning in the study by Esteban et al 25 may have made it more difficult for patients in the PS group to meet extubation criteria than patients in the other groups.
The study by Jounieaux et al 24 of SIMV and PS vs SIMV suggests the superiority of a regimen that includes PS by its finding of a shorter weaning time in the PS group. Because of the small sample size and low event rates, the study provides very little information about the effects on outcomes of nonextubation or reintubation. The most dramatic finding in studies of progressive reduction in ventilatory support comes from two small, but sound, RCTs 26, 27 that suggest that NPPV is markedly superior to PS with or without CPAP. While these results are intriguing, the randomized trials that addressed this question enrolled a total of Ͻ 100 patients. However, the promising results of these studies are reinforced by the unequivocal results of systematic reviews of NPPV in patients with exacerbations of COPD who were on the threshold of ventilatory failure that demonstrate mortality benefits in favor of NPPV. An investigation of early NPPV in patients receiving mechanical ventilation should be one of the top priorities in this area of clinical research.
The data included in this systematic review and a more comprehensive discussion of the original articles are included in an Evidence Report of the Agency for Healthcare Research and Quality. 35 
